Drug Approval | July 11, 2025
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
_256_384.jpg)
33rd lab in Thyrocare’s expanding network to bring advanced, affordable diagnostic services across the Kashmir Valley
Speakers for the session are: Dr. Richard Lobo, Global Head Business Excellence, Innovation, R&D and Chief Ethics Counsellor, Tata Chemicals; Dr. Debabrata Rautaray, Vice President and Chief Product Development & Innovation Officer, DCM Shriram Chemicals Innovation Centre; Dr. Prashant Puri, Head - R&D, Deepak Fertilizers and Petrochemicals Corporation (DFPCL); Dr. Deepak S Panmand, General Manager (R&D), Dhanuka Agritech; Dr. Mudassir. K. Munshi, Team Leader, Deepak Nitrite; and Dr. Manish M. Khandagale, Senior Field Application Specialist, Revvity Signals
Subscribe To Our Newsletter & Stay Updated
